Cullinan Oncology is a biopharmaceutical company focused on developing targeted therapeutics to create new standards of care for patients, especially in the fields of oncology, immunology, and translational medicine. With a unique approach to research and development, they identify high-impact targets and pursue the best modality to maintain a deep and diverse pipeline of transformative therapies. Cullinan Oncology emphasizes collaboration both internally and with external academic and industry partners, with the goal of efficiently advancing promising therapies for cancer and autoimmune indications. Their approach is modality-agnostic, aiming to leverage the best scientific collaborations to benefit patients.
Oncology
11 - 50 employees
Founded 2018
𧬠Biotechnology
π Pharmaceuticals
π° $10M Post-IPO Equity on 2022-03
2 days ago
Manage regulatory submissions and strategies for a biopharmaceutical company focused on innovative cancer therapies.
πΊπΈ United States β Remote
π° $10M Post-IPO Equity on 2022-03
β° Full Time
π Senior
π Compliance
November 28
Join Cullinan Therapeutics as a competitive intelligence professional, focusing on oncology programs.
πΊπΈ United States β Remote
π° $10M Post-IPO Equity on 2022-03
β° Full Time
π΄ Lead
π Director
October 30
Director of Drug Product Manufacturing for oncology and autoimmune biopharmaceuticals.
πΊπΈ United States β Remote
π° $10M Post-IPO Equity on 2022-03
β° Full Time
π΄ Lead
π Director
October 4
Quality Assurance Manager at a biopharmaceutical company ensuring compliance and quality standards.
πΊπΈ United States β Remote
π° $10M Post-IPO Equity on 2022-03
β° Full Time
π Senior
π§ QA Engineer (Quality Assurance)
September 27
Pharmacovigilance Scientist at Cullinan Therapeutics developing safety strategies for products.
πΊπΈ United States β Remote
π° $10M Post-IPO Equity on 2022-03
β° Full Time
π Senior
π Director